文献速递消化道肿瘤放疗放疗物理与技术姑息放疗与转移瘤

直肠癌放疗后骨盆功能不全骨折与剂量体积参数及计划优化

Pelvic insufficiency fractures, dose volume parameters and plan optimization after radiotherapy for rectal cancer.
PubMed 文献 · Clin Transl Radiat Oncol · 2019-09-10

该研究纳入27例接受放化疗的直肠癌患者,3年后MRI发现9例(33%)骨盆功能不全骨折。骨折患者骨盆骨受量普遍更高,骶髂关节V30Gy无显著差异(68.5% vs 56%,p=0.064)。计划比较显示3弧VMAT和质子束治疗骨保护能力最强。

要点

  • 直肠癌放化疗后3年骨盆功能不全骨折发生率达33%。
  • 骨折患者骶髂关节V30Gy有更高趋势但未达统计学显著。
  • 3弧VMAT和质子束治疗可优化骨盆骨保护。

核心结论

  • 基于VMAT的直肠癌放化疗后3年骨盆功能不全骨折发生率高,骨折患者骶髂关节受量有更高趋势。

研究设计与样本

  • 回顾性纳入27例(18男,平均64岁)接受放化疗的原发直肠癌患者,行3年骨盆MRI识别骨折并回顾勾画骨结构、重算剂量体积直方图。

主要发现

  • 9例(33%)发现骨盆功能不全骨折,其中6例为多部位骨折。
  • 骨折患者骨盆骨受量普遍更高,骶髂关节V30Gy为68.5%(60.1-69.3 IQR)vs 56%(54.1-66.6 IQR),p=0.064。

关键数值与推荐

  • 骶髂关节V30Gy骨折组68.5%(60.1-69.3 IQR)vs 无骨折组56%(54.1-66.6 IQR),p=0.064。

临床怎么用

  • 直肠癌VMAT放化疗计划中可考虑评估骨盆骨剂量,3弧VMAT和质子束治疗具有更强骨保护潜力。

局限性

  • 样本量小(27例)且为回顾性设计,结果需在更大样本、前瞻性队列中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Pelvic insufficiency fractures (PIF) is a known but under-acknowledged late effect of pelvic radiotherapy. In rectal cancer, studies describing incidence of PIF and relation to dose volume relationships are lacking. The aim of this study was (i) to analyse dose volume histograms (DVH) from pelvic bones in patients with and without PIF, and (ii) to determine bone sparing capacity of 2 and 3 arc volumetric arc therapy (VMAT), intensity modulated radiotherapy (IMRT) and proton beam therapy (PBT), in rectal cancer patients treated with chemoradiotherapy (CRT). MATERIAL AND METHODS: Patients treated with CRT for primary rectal cancer underwent a 3-year pelvic MRI for identification of PIFs. Bone structures were retrospectively delineated, and DVHs were re-calculated. Comparative planning was done with 2 (original) and 3 arc VMAT, fixed field IMRT and PBT plans. RESULTS: 27 patients (18 men, mean age 64 years) were included and PIFs were identified in 9 (33%), most (n = 6) had multiple fracture sites. In general, patients with PIFs received higher doses to pelvic bones, and V30 Gy to the sacroiliac joint was non-significantly higher in patients with PIF 68.5% (60.1-69.3 IQR) vs. 56% (54.1-66.6 IQR), p = 0.064. Comparative planning showed that especially 3 arc VMAT and proton beam therapy could be optimized for bone. CONCLUSIONS: Patients, treated with VMAT based CRT for rectal cancer, have high rates of PIFs after 3 years. Patients with PIFs tended to have received higher doses to sacroiliac joints. Comparative planning demonstrated most pronounced bone sparing capacity of 3 arc VMAT and with PBT having the potential to further lower doses. These results should be validated in larger and preferably prospective cohorts.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Kronborg CJS, Jørgensen JB, Petersen JBB, et al. Pelvic insufficiency fractures, dose volume parameters and plan optimization after radiotherapy for rectal cancer. Clin Transl Radiat Oncol. 2019. PMID: 31646202. doi:10.1016/j.ctro.2019.09.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。